de Verneuil Vanina
EVP, General Counsel, Corp Sec
de Verneuil Vanina has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Feb 26, 2026.
On the most recent filing, de Verneuil Vanina is listed as EVP, General Counsel, Corp Sec at Vir Biotechnology, Inc. Inside the rolling window, de Verneuil Vanina reported no open-market purchases and 5 open-market sales totaling $218K in VIR. The largest disclosed transaction in the window is a sale of 13,700 VIR shares on Feb 25, 2026, worth $135K.
Companies traded
Other insiders at VIR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$218K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has de Verneuil Vanina made?
de Verneuil Vanina has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does de Verneuil Vanina trade?
de Verneuil Vanina has filed SEC Form 4 disclosures for 1 company, including VIR.
When was de Verneuil Vanina's most recent SEC Form 4 filing?
de Verneuil Vanina's most recent SEC Form 4 filing on Tracefour is dated Feb 26, 2026.
What is de Verneuil Vanina's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, de Verneuil Vanina is listed as EVP, General Counsel, Corp Sec.
What is de Verneuil Vanina's total buy and sell value in the current window?
Inside the rolling retention window, de Verneuil Vanina bought $0 and sold $218K based on SEC Form 4 filings.
What was de Verneuil Vanina's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 13,700 VIR shares on 2026-02-25, worth $135K, per SEC Form 4 filings.